Alimera Sciences fails to get FDA approval for Iluvien. Iluvien is a sustained release drug delivery system that releases a steroid into the eye for the treatment of diabetic macular edema. Alimera received the denial late last week in a letter from the FDA.
Implant Too Risky
In short, the FDA still has concerns about the safety of the new drug. Original concerns about cataract formation and IOP (intraocul (Read more...)